Xcout Intel
Kriya Therapeutics
Kriya Therapeutics, Inc. is a fully integrated biopharmaceutical company with operational footprints in Redwood City, California, and Research Triangle Park, North Carolina. The company develops novel gene therapies to address diverse diseases.
Subscribe to see Kriya Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Kriya Therapeutics at a glance
Kriya Therapeutics is a biotechnology company headquartered in United States. It has raised at least $957.1M across the 5 funding rounds on record. Its most recent funding round, Series D, raised $320M in September 2025. Xcout tracks 33 named people at Kriya Therapeutics, including Shankar Ramaswamy (Chief Executive Officer). Xcout recorded 2 job postings from Kriya Therapeutics in the last 90 days.
Kriya Therapeutics leadership
- Shankar RamaswamyChief Executive Officer
- Mark ChenChief Operating Officer
- Sachiyo MinegishiChief Financial Officer
- Brian FurmanskiChief Development Officer
- Britt PettyChief Manufacturing Officer
- Greg Di RussoChief Medical Officer
27 more named people on record for Kriya Therapeutics, with roles, board committees and tenure — see the full roster →
Kriya Therapeutics funding rounds
At least $957.1M raised across the 5 rounds on record. The 3 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series D | $320M | 5 named | |
| SEC Form D filing | $361.8M | — | |
| Seed | $100M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Kriya Therapeutics
Xcout recorded 2 job postings from Kriya Therapeutics in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Kriya Therapeutics's hiring signals →
Investors
Kriya Therapeutics competitors
A few of Kriya Therapeutics's closest competitors — see the full list of competitors and alternatives →
ReCode Therapeutics is a clinical-stage genetic medicines company headquartered in Menlo Park, California, and Durham, North Carolina. The company leverages proprietary delivery systems to power a new class of disease-modifying genetic therapies.
Atsena Therapeutics, Inc. is a clinical-stage gene therapy company headquartered in Durham, North Carolina, established in 2019. The firm focuses on developing novel gene therapies to treat debilitating inherited blinding diseases using proprietary vector delivery technologies. Its scientific pipeline aims to address areas of high unmet medical need in ophthalmology.
Encoded Therapeutics is a biotechnology company headquartered in South San Francisco, California, dedicated to developing next-generation genetic medicines designed to address the root causes of genetic diseases.
Adverum Biotechnologies is a clinical-stage biotechnology research company headquartered in Redwood City, California. The company focuses on developing novel gene therapies designed to redefine ocular care and treat severe eye diseases.
Gemma Labs Inc. (GEMMABio) is a biotechnology company that develops gene therapies for rare diseases using next-generation AAV technology. The company focuses on programs targeting motor neuron disorders, skeletal conditions, and cardiomyopathies to serve the rare disease community.
Ray Therapeutics, Inc. is a privately held optogenetic gene therapy company headquartered in Berkeley, California. The company focuses on reimagining vision through innovative genetic treatments and novel therapeutic solutions.
Get Kriya Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Kriya Therapeutics in Xcout Intel
- 33 named people with titles, LinkedIn and board committees
- 5 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access